Menu
Recruiting NCT07228611

Assesment and Comparison of Osteoporosis Risk Factors After Stroke

Observational Stroke Osteoporosis

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Bone Mineral Density.
Who it may be relevant to
Registry conditions: Stroke Osteoporosis. Basic parameters: 55 years — 85 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Comparison of Osteoporosis Risk in the Subacute and Chronic Periods Following Stroke and Evaluation of Factors Increasing Osteoporosis

Overview

The aim of this study is to evaluate the effect of these factors and stroke itself on osteoporosis developing after stroke. Thus, the expected benefit of the study is to contribute to the identification and determination of the need for treatment in high-risk patients through further studies. There are no expected risks from the study.

Interventions

  • Diagnostic test Bone Mineral Density
    Patients who have had a stroke and are at risk of fracture, and for whom routine assessment requires Bone Mineral Density (BMD) testing, will be included in the study. In addition, patients who have already undergone BMD testing for osteoporosis screening and who present to the outpatient clinic, with similar age and comorbidities, will be screened from the system, and 28 non-stroke patients who agree to participate will be included in the study.

Primary outcome measures

  • Bone Mineral Density [Time frame: First day of hospitalization]
Secondary outcome measures (7)
  • Brunnstrom [Time frame: First day of hospitalization]
  • Modified Barthel Index [Time frame: First day of hospitalization]
  • Modified Ashworth Scale [Time frame: First day of hospitalization]
  • Modified Fall Impact Scale [Time frame: First day of hospitalization]
  • Vitamin D, prealbumin, and albumin [Time frame: First day of hospitalization]
  • Baseline Digital Hand Dynamometer 198 LB/90 kg [Time frame: First day of hospitalization]
  • Measurements of quadriceps muscle thickness and biceps muscle thickness [Time frame: First day of hospitalization]

Eligibility criteria

Inclusion criteria

  • Followed by ischemic or hemorrhagic stroke
  • Between 1 week and 6 months or >1 year has passed since the date of the event
  • Being between 55 and 85 years of age

Exclusion criteria

  • The patient has additional neurological conditions besides stroke
  • The patient has a psychiatric condition
  • History of recurrent stroke
  • BMD scan performed within the last year for stroke patients
  • Having received osteoporosis treatment before or after the stroke
  • The patient having a fragility fracture before the stroke
  • The patient having a hip fracture or hip prosthesis
  • The patient having an additional condition that affects physical function before the stroke (amputation, severe fracture)
  • The patient has an additional disease or medication use that could cause secondary osteoporosis
  • The patient's stroke did not cause physical function loss

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Other

Study locations

Turkey (Türkiye) · 1 center
  • Ankara Etlik City Hospital — Ankara

Identifiers

NCT: NCT07228611 · AEŞH-BADEK-2025-478

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗